Skip to content

ABLD · Euronext Paris · ISIN FR001400AHX6

ABL Texcell Diagnostics, Advanced Biological Laboratories

Company news

WEB TV INterview: ABL Diagnostics fait le point sur son activité

Web TV Interview: ABL Diagnostics fait le point sur son activité

We are happy to share our first webTV interview during which we have explained ABL Diagnostics activity and the development of our market. Co-founders of ABL Group: Dr Sayada & M. Boulmé talked about the original IPO via a reverse take over and they detailed the future operations to improve the stock's liquidity.

Feel free to contact us (contact@abldiagnostics.com) if you have questions, especially for non-french speakers.

See all